By Counterforce Health Team in Raxone (idebenone) —

Getting Raxone (Idebenone) Covered by Humana in Ohio: Complete Prior Authorization & Appeal Guide

Quick Answer: Raxone (idebenone) for LHON requires prior authorization from Humana Medicare Advantage plans in Ohio. Since it's not FDA-approved in the US, coverage depends on proving medical necessity through genetic testing, clinical documentation, and international evidence. If denied, you have 65 days to appeal internally, then can request external review through Ohio's Department of Insurance within 180 days. Start by gathering your LHON genetic test results and having your doctor submit a detailed prior authorization request through Humana's provider portal.

Table of Contents

How to Use This Guide

This guide helps patients with Leber Hereditary Optic Neuropathy (LHON) navigate getting Raxone (idebenone) covered by Humana in Ohio. Since Raxone isn't FDA-approved in the US but is approved in the EU and UK, coverage requires demonstrating exceptional medical necessity.

Important: Raxone is not eligible for standard Medicare Part D formulary exceptions because it lacks FDA approval. However, some Medicare Advantage plans may cover it under medical benefits or through special exception processes.

Start by determining your eligibility level using the assessment below, then follow the corresponding action plan.

Eligibility Assessment

Likely Eligible ✅

You probably qualify if you have all of these:

  • Confirmed LHON diagnosis with genetic testing showing one of the three primary mutations (11778, 3460, or 14484)
  • Age 12 or older
  • Visual acuity loss within the past 5 years
  • No contraindications to idebenone
  • Documentation of failed or inappropriate alternative treatments

Possibly Eligible ⚠️

You may qualify with additional documentation if you have:

  • Clinical LHON diagnosis but genetic testing pending
  • LHON family history with compatible symptoms
  • Other mitochondrial mutations associated with optic neuropathy
  • Visual loss outside the typical LHON timeframe but with supporting evidence

Not Yet Eligible ❌

You'll need more preparation if:

  • No confirmed LHON diagnosis
  • Missing genetic testing results
  • Age under 12 (pediatric considerations apply)
  • Significant contraindications without mitigation plans

If You're Likely Eligible

Document Checklist

Gather these materials before submitting:

Medical Records

  • Genetic test results confirming LHON mutation
  • Ophthalmologic examination reports with visual acuity measurements
  • Optical coherence tomography (OCT) results showing retinal nerve fiber layer changes
  • Family history documentation
  • Prior treatment records (if any)

Insurance Documentation

  • Current Humana member ID card
  • Summary of Benefits (verify if drug coverage is under medical or pharmacy benefit)
  • Prior authorization form (obtain from provider portal)

Submission Path

  1. Contact your prescribing physician (preferably a neuro-ophthalmologist) to initiate the prior authorization
  2. Submit through Humana's provider portal at provider.humana.com
  3. Include international evidence: EU approval documents, NICE recommendations, and published clinical trials
  4. Request expedited review if vision loss is progressing rapidly
Tip: Since idebenone is considered a specialty medication, ensure your provider submits to both the pharmacy and medical benefits departments, as coverage pathways may vary.

If You're Possibly Eligible

Tests to Request

Work with your healthcare team to obtain:

  • Comprehensive genetic testing for mitochondrial DNA mutations
  • Complete ophthalmologic workup including visual fields, color vision testing, and fundus photography
  • Family screening if genetic results support hereditary pattern

What to Track

  • Document all vision changes with dated measurements
  • Keep records of any treatments attempted
  • Monitor for additional family members with similar symptoms

Timeline to Re-apply

  • Allow 4-6 weeks for genetic testing results
  • Resubmit prior authorization within 30 days of receiving confirmatory tests
  • Consider interim supportive care and vision rehabilitation services

If You're Not Yet Eligible

Alternatives to Discuss

While working toward LHON confirmation:

  • Supportive supplements: Coenzyme Q10 and other mitochondrial nutrients (limited evidence but may provide some benefit)
  • Low vision rehabilitation: Occupational therapy and assistive devices
  • Lifestyle modifications: Avoid smoking and excessive alcohol, which can trigger LHON expression

Prepare for Exception Requests

Even without FDA approval, document:

  • Why standard treatments are inappropriate
  • International evidence supporting idebenone use
  • Potential for significant functional improvement
  • Risk-benefit analysis specific to your case

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform can help identify the specific denial basis and craft point-by-point rebuttals aligned with Humana's policies, pulling appropriate international evidence and clinical documentation for complex cases like non-FDA approved medications.

If You're Denied Coverage

Internal Appeals Process

Timeline: 65 days from denial notice to file appeal

Level 1 - Standard Reconsideration

  • Submit written appeal to Humana
  • Include additional medical evidence
  • Request peer-to-peer review with ophthalmologist
  • Decision within 30 days (7 days if expedited)

Level 2 - Independent Review

  • Automatic if Level 1 denied
  • Reviewed by independent medical professionals
  • Decision within 30 days

Ohio External Review Process

If internal appeals fail, Ohio residents can request external review through the Ohio Department of Insurance.

Key Facts:

  • Deadline: 180 days from final internal denial
  • Timeline: 30 days for standard review, 72 hours for expedited
  • Cost: No fee to patient
  • Decision: Binding on Humana

How to Request:

  1. Submit written request to Humana (they forward to ODI)
  2. Include all supporting documentation
  3. Specify if expedited review needed
  4. Contact ODI at 800-686-1526 for assistance
Note: Self-funded employer plans follow federal ERISA rules, not Ohio's external review process. Check your plan documents to determine if you have a fully-insured plan eligible for Ohio's process.

Appeals Process Flowchart

Prior Authorization Denied
↓
Internal Appeal Level 1 (65 days to file)
↓ (if denied)
Internal Appeal Level 2 (automatic)
↓ (if denied)
Ohio External Review (180 days to file)
↓
Independent Review Organization Decision (binding)

Resources and Verification

Official Forms and Contacts

Clinical Resources

FAQ

How long does Humana prior authorization take for Raxone in Ohio? Standard decisions within 72 hours; expedited within 24 hours if medically urgent. Complex cases involving non-FDA approved drugs may take longer.

What if Raxone is completely non-formulary? Since it's not FDA-approved, it won't be on any Medicare Part D formulary. Coverage must be sought as a medical exception or under medical benefits.

Can I request an expedited appeal if my vision is worsening? Yes, if your physician certifies that waiting would seriously jeopardize your health. Both internal appeals and Ohio external review offer expedited timelines.

Does Humana require step therapy for LHON treatments? There are no FDA-approved alternatives, so traditional step therapy doesn't apply. However, Humana may require documentation that supportive treatments were considered.

What documentation strengthens my medical necessity case? Genetic test confirmation, progressive vision loss documentation, family history, international clinical trial data, and expert physician opinion on lack of alternatives.

How much does Raxone cost without insurance? International pricing varies significantly. UK list price is approximately £6,364 per 180-tablet pack. Patient assistance programs may be available through the manufacturer.

When navigating complex prior authorization cases like Raxone, having expert support can make the difference between approval and denial. Counterforce Health's platform analyzes denial letters and plan policies to create targeted appeals that address specific payer requirements, particularly valuable for non-FDA approved medications requiring extensive international evidence.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances and plan specifics. Always consult with your healthcare provider and insurance company for personalized guidance. For official Ohio insurance appeals information, contact the Ohio Department of Insurance at 800-686-1526 or visit insurance.ohio.gov.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.